Heparanase, galectin-3, and tissue factor mRNA are expressed in benign neoplasms of the thyroid

[1]  A. Miyauchi,et al.  Outcome of long standing solitary thyroid nodules , 1992, World Journal of Surgery.

[2]  E. Kimura,et al.  Galectin-3 messenger ribonucleic acid and protein are expressed in benign thyroid tumors. , 2002, The Journal of clinical endocrinology and metabolism.

[3]  John L. Wang,et al.  Intracellular functions of galectins. , 2002, Biochimica et biophysica acta.

[4]  D. Ross.  Nonpalpable thyroid nodules--managing an epidemic. , 2002, The Journal of clinical endocrinology and metabolism.

[5]  P. De Giuli,et al.  Galectin-3 as a presurgical immunocytodiagnostic marker of minimally invasive follicular thyroid carcinoma. , 2001, The Journal of clinical endocrinology and metabolism.

[6]  I. Vlodavsky,et al.  Molecular properties and involvement of heparanase in cancer progression and normal development. , 2001, Biochimie.

[7]  I. Pecker,et al.  The FASEB Journal express article 10.1096/fj.00-0895fje. Published online May 29, 2001. , 2022 .

[8]  A. Vecchione,et al.  Application of an immunodiagnostic method for improving preoperative diagnosis of nodular thyroid lesions , 2001, The Lancet.

[9]  T. Peretz,et al.  Expression of heparanase in normal, dysplastic, and neoplastic human colonic mucosa and stroma. Evidence for its role in colonic tumorigenesis. , 2000, The American journal of pathology.

[10]  M. P. Martegani,et al.  Galectin-3 and CD44v6 isoforms in the preoperative evaluation of thyroid nodules. , 1999, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[11]  O. Pappo,et al.  Mammalian heparanase: Gene cloning, expression and function in tumor progression and metastasis , 1999, Nature Medicine.

[12]  Y. Gruel,et al.  Fast detection of tissue factor and tissue factor pathway inhibitor messenger RNA in endothelial cells and monocytes by sensitive reverse transcription-polymerase chain reaction. , 1999, Thrombosis research.

[13]  P. De Giuli,et al.  Galectin-3 is a presurgical marker of human thyroid carcinoma. , 1998, Cancer research.

[14]  S. Savin,et al.  Immunohistochemical localization of galectin-3 in malignant and benign human thyroid tissue. , 1998, Anticancer research.

[15]  K. Nabeshima,et al.  Analysis of tissue factor and tissue factor pathway inhibitor expression in human colorectal carcinoma cell lines and metastatic sublines to the liver , 1997, International journal of cancer.

[16]  W. Ruf,et al.  Tissue factor in cancer angiogenesis and metastasis , 1996, Current opinion in hematology.